New guidelines for diagnosis and treatment of sickle cell disease were recently issued by a federally sponsored panel of independent experts, with the support of the Agency for Health Policy and Research.

The guidelines include recommendations for universal screening of newborns, protective doses of penicillin to ward off infection, and follow-up medical care. Universal screening currently is performed in 34 states and jurisdictions, and targeted screening is done in others, according to the U.S. Department of Health and Human Services.

This content is only available via PDF.
You do not currently have access to this content.